Food Challenge and Research Unit, Section of Allergy, and Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado.
Ann Allergy Asthma Immunol. 2020 Sep;125(3):262-267. doi: 10.1016/j.anai.2020.05.031. Epub 2020 Jun 3.
Shared decision-making is a patient-centered approach that involves a mutual discussion about management or treatment options, which account for the patient's underlying values and preferences for therapy. Little is known about the role of shared decision-making in the care of patients with food allergy.
A narrative review of the shared decision-making and food allergy outcomes literature in the past 20 years was performed.
In shared decision-making, care must be taken to help clarify the patient's values regarding their care options, but not instill the clinician's values or preferences into that choice. It is essential to understand the mutual roles of the clinician in the process of providing evidence-based options for care, advocating for treatments that are aligned with their goals and preferences, and allowing patients to make fully informed decisions within this paradigm. Decision support tools such as decision aids can assist patients in the values clarification process, particularly in which preference-sensitive care exists, in which options hold significant tradeoffs and varying outcomes, and the decision is reflective of personal values and preferences. There are multiple potential preference-sensitive care scenarios in food allergy in which shared decision-making could be optimized, including the development of decision aids. These areas include early allergenic solid introduction, preemptive epinephrine use in which there is allergen exposure but no symptoms, automatic activation of EMS after using epinephrine, and choices of food allergy treatment. Only one decision aid in food allergy exists.
Shared decision-making is an approach that could greatly enhance food allergy care and improve patient-reported outcomes.
共同决策是一种以患者为中心的方法,涉及共同讨论管理或治疗方案,这些方案考虑了患者对治疗的潜在价值观和偏好。关于共同决策在食物过敏患者护理中的作用知之甚少。
对过去 20 年中共同决策和食物过敏结果文献进行了叙述性综述。
在共同决策中,必须注意帮助澄清患者对其护理选择的价值观,但不要将临床医生的价值观或偏好强加于该选择。了解临床医生在提供基于证据的护理选择、倡导与他们的目标和偏好一致的治疗方法以及允许患者在这一范式下做出充分知情决策过程中的相互作用至关重要。决策支持工具,如决策辅助工具,可以帮助患者澄清价值观的过程,特别是在存在偏好敏感护理的情况下,在这种情况下,存在重要的权衡和不同的结果,并且决策反映了个人价值观和偏好。在食物过敏中存在多种潜在的偏好敏感护理情况,可以优化共同决策,包括开发决策辅助工具。这些领域包括早期致敏固体引入、在有过敏原暴露但无症状时预先使用肾上腺素、使用肾上腺素后自动激活 EMS 以及食物过敏治疗的选择。目前仅存在一种食物过敏决策辅助工具。
共同决策是一种可以极大地增强食物过敏护理并改善患者报告结果的方法。